The complaint, filed by the law firm Bronstein, Gewirtz & Grossman, LLC, alleges that Endava failed to disclose that its customer and supplier agreements required deeper review. This oversight triggered a delay in the release of the company’s fourth-quarter and full-year 2026 financial results, undermining the accuracy of public statements regarding the firm's operations. Plaintiffs claim these omissions left investors without a reasonable basis to evaluate the company's true performance.

Shareholders who acquired Endava securities during the specified period have until November 30, 2026, to petition the court to serve as lead plaintiff. While the firm operates on a contingency fee basis, investors are not required to take on a lead role to participate in any potential recovery. Those interested in reviewing the complaint or discussing the case may contact Peretz Bronstein or Nathan Miller at 917-590-0911.